FDA has revised its internal Twitter policy to match its guidance to industry, but the Pharmaceutical Research and Manufacturers of America argues that companies should be able to use the agency’s previous format in their own tweets about drug approvals.
In comments on FDA’s draft guidance on social media platforms with character space limitations, PhRMA contends that the...